1. Kabanov AV, Vinogradov SV (2009). Nanogels as pharmaceutical carriers: finite networks of
infinite capabilities.Angew Chem Int Ed Engl. 48(30): 5418-29.
2. Zhang H, Mitin A, Vinogradov SV (2009). Efficient transfection of blood-brain barrier endothelial
cells by lipoplexes and polyplexes in the presence of nuclear targeting NLS-PEG-acridine
conjugates. Bioconjug Chem 20(1): 120-8.
3. Galmarini CM, Warren G, Kohli E, Zeman A, Mitin, A, Vinogradov SV (2008). Polymeric nanogels
containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against
breast and colorectal cancer cell lines. Mol Cancer Ther 7(10), 3373-3380.
4. Kabanov AV, Vinogradov SV (2008). Nanogels as pharmaceutical carriers. In: Multifunctional
Pharmaceutical Nanocarriers (Ed. by Victor Torchilin), Springer, 2008.
5. Vinogradov SV, Mitin A, Warren G (2008). Folate-targeted polyformulations of cytotoxic nucleoside
triphosphates and paclitaxel. Polymer Prepr (American Chemical Society, Division of Polymer
Chemistry), 49(2), 1050-1051.
6. Yi Xiang, Batrakova E, Banks WA, Vinogradov S, Kabanov AV (2008). Protein Conjugation with
Amphiphilic Block Copolymers for Enhanced Cellular Delivery. Bioconjug Chem, 19(5), 1071-1077.
7. Vinogradov SV, Zhang, Hongwei, Mitin A, Warren G (2008). Intercalating conjugates of PEG with
nuclear localization signal (NLS) peptide. Polymer Prepr (American Chemical Society, Division of
Polymer Chemistry), 49(2), 434-435.
8. Kohli E, Han H-Y, Zeman AD, Vinogradov SV (2007) Formulations of biodegradable Nanogel
carriers with 5’-triphosphates of nucleoside analogs that display a reduced cytotoxicity and
enhanced drug activity. J Contr Release 121: 19-27.
9. Vinogradov SV (2007) Polymeric nanogel formulations of nucleoside analogs. Expert Opin Drug
Deliv 4: 5-17.
10. Vinogradov SV (2006) Colloidal microgels in drug delivery applications. Curr Pharm Design 12:
4703-12.
11. Vinogradov SV, Kohli E, Zeman AD (2006) Comparison of Nanogel drug carriers and their
formulations with nucleoside 5’-triphosphates. Pharm Res 23: 920-930.
12. Vinogradov SV, Kohli E, Zeman A, Kabanov AV (2006). Chemical engineering of nanogel drug
carriers: increased bioavailability and decreased cytotoxicity. Polymer Prepr. (American Chemical
Society, Division of Polymer Chemistry), 47(2): 27-28.
13. Vinogradov SV, Zeman AD, Batrakova EV, Kabanov AV (2005) Polyplex Nanogel formulations for
drug delivery of cytotoxic nucleoside analogs. J Contr Release 107: 143-157.
14. Vinogradov SV, Kohli E, Zeman AD (2005) Cross-linked polymeric Nanogel formulations of 5’triphosphates of nucleoside analogs: role of the cellular membrane in drug release. Mol Pharm 2:
449-461.
15. Batrakova EV, Vinogradov SV, Robinson SM, Niehoff ML, Banks WA, Kabanov AV. Polypeptide
point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery.
Bioconjug Chem. 16(4): 793-802.
16. Vinogradov SV, Batrakova EV, Kabanov AV (2004). Nanogels for oligonucleotide delivery to the
brain. Bioconjug Chem 15: 50-60.
17. Vinogradov SV, Batrakova EV, Shu Li, Kabanov AV (2004). Mixed Polymer Micelles of Amphiphilic
and Cationic Copolymers for Delivery of Antisense Oligonucleotides. J Drug Target 12: 517-526.
18. Vinogradov S (2004). The second annual symposium on nanomedicine and drug delivery:
exploring recent developments and assessing major advances. Expert Opin Drug Deliv 1:181-184.
19. Batrakova EV; Yan Zhang; Yili Li; Shu Li; Vinogradov SV; Persidsky Y; Alakhov VY; Miller DW,
Kabanov AV (2004). Effects of Pluronic P85 on GLUT1 and MCT1 Transporters in the Blood Brain
Barrier. Pharm Res 21: 1993-2000.
20. Belenkov AI, Alakhov VY, Kabanov AV, Vinogradov SV, Panasci LC, Monia BP, Chow TYK
(2004). Polyethyleneimine grafted with pluronic p85 enhances ku86 antisense delivery and the
ionizing radiation treatment efficacy in vivo. Gene Ther 11: 1665-72.